259 related articles for article (PubMed ID: 15372159)
1. [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].
Heinz A; Braus DF; Romero B; Gallinat J; Puls I; Juckel G; Weinberger DR
Nervenarzt; 2004 Sep; 75(9):845-56. PubMed ID: 15372159
[TBL] [Abstract][Full Text] [Related]
2. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
3. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
Deakin FW; Simpson MD; Slater P; Hellewell JS
J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
[TBL] [Abstract][Full Text] [Related]
4. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
Bertolino A; Caforio G; Blasi G; De Candia M; Latorre V; Petruzzella V; Altamura M; Nappi G; Papa S; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
Am J Psychiatry; 2004 Oct; 161(10):1798-805. PubMed ID: 15465976
[TBL] [Abstract][Full Text] [Related]
5. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
7. Molecular brain imaging and the neurobiology and genetics of schizophrenia.
Heinz A; Romero B; Gallinat J; Juckel G; Weinberger DR
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S152-7. PubMed ID: 14677072
[TBL] [Abstract][Full Text] [Related]
8. The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication.
da Silva Alves F; Figee M; van Amelsvoort T; Veltman D; de Haan L
Psychopharmacol Bull; 2008; 41(1):121-32. PubMed ID: 18362875
[TBL] [Abstract][Full Text] [Related]
9. The role of limbic and cortical regions in schizophrenia: focus on dopamine.
Marchese G; Pani L
Eur Psychiatry; 2002 Aug; 17 Suppl 4():349s-354s. PubMed ID: 23573604
[TBL] [Abstract][Full Text] [Related]
10. Executive functioning component mechanisms and schizophrenia.
Kerns JG; Nuechterlein KH; Braver TS; Barch DM
Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
[TBL] [Abstract][Full Text] [Related]
11. Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.
Hu M; Zong X; Zheng J; Mann JJ; Li Z; Pantazatos SP; Li Y; Liao Y; He Y; Zhou J; Sang D; Zhao H; Tang J; Chen H; Lv L; Chen X
Psychol Med; 2016 Sep; 46(12):2549-60. PubMed ID: 27338296
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
13. Changes over time in frontotemporal activation during a working memory task in patients with schizophrenia.
Wolf RC; Vasic N; Höse A; Spitzer M; Walter H
Schizophr Res; 2007 Mar; 91(1-3):141-50. PubMed ID: 17258892
[TBL] [Abstract][Full Text] [Related]
14. Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia.
Wolf RC; Vasic N; Sambataro F; Höse A; Frasch K; Schmid M; Walter H
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1464-73. PubMed ID: 19666074
[TBL] [Abstract][Full Text] [Related]
15. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
[TBL] [Abstract][Full Text] [Related]
16. Theory of mind network activity is altered in subjects with familial liability for schizophrenia.
Mohnke S; Erk S; Schnell K; Romanczuk-Seiferth N; Schmierer P; Romund L; Garbusow M; Wackerhagen C; Ripke S; Grimm O; Haller L; Witt SH; Degenhardt F; Tost H; Heinz A; Meyer-Lindenberg A; Walter H
Soc Cogn Affect Neurosci; 2016 Feb; 11(2):299-307. PubMed ID: 26341902
[TBL] [Abstract][Full Text] [Related]
17. The frontal lobes and schizophrenia.
Weinberger DR; Aloia MS; Goldberg TE; Berman KF
J Neuropsychiatry Clin Neurosci; 1994; 6(4):419-27. PubMed ID: 7841813
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenic deficits: neuroleptics and the prefrontal cortex.
Jobe TH; Harrow M; Martin EM; Whitfield HJ; Sands JR
Schizophr Bull; 1994; 20(3):413-6; discussion 417-21. PubMed ID: 7973463
[TBL] [Abstract][Full Text] [Related]
19. Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia.
Ragland JD; Gur RC; Valdez J; Turetsky BI; Elliott M; Kohler C; Siegel S; Kanes S; Gur RE
Am J Psychiatry; 2004 Jun; 161(6):1004-15. PubMed ID: 15169688
[TBL] [Abstract][Full Text] [Related]
20. Effect of rTMS on brain activation in schizophrenia with negative symptoms: A proof-of-principle study.
Dlabac-de Lange JJ; Liemburg EJ; Bais L; Renken RJ; Knegtering H; Aleman A
Schizophr Res; 2015 Oct; 168(1-2):475-82. PubMed ID: 26187147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
